1. The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer

   • Hans F. A. Vasen

   Editorial 04 December 2017 Pages: 1 - 3

2. Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

   • R. El Tannouri
   • E. Albuisson
   • E. Luporsi

   Original Article 10 May 2017 Pages: 5 - 14

3. Heightened perception of breast cancer risk in young women at risk of familial breast cancer

   • Rachael Glassey
   • Moira O’Connor
   • Sarah J. Hardcastle

   Original Article 13 May 2017 Pages: 15 - 22

4. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia

   • A. M. Cock-Rada
   • C. A. Ossa
   • L. R. Gomez

   Original Article 20 May 2017 Pages: 23 - 30

   

5. Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries

   • Anne Brédart
   • Jean-Luc Kop
   • Rita Schmutlzer

   Original Article Open access 16 June 2017 Pages: 31 - 41

   

6. The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis

   • Neil Donald
   • Salim Malik
   • Kevin J. Monahan

   Review Open access 15 May 2017 Pages: 43 - 52

   

7. Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers

   • Holly Etchegary
   • Elizabeth Dicks
   • Lesa Dawson

   Original Article 27 May 2017 Pages: 53 - 61

8. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers

   • Lochlan J. Fennell
   • Mark Clendenning
   • Vicki L. J. Whitehall

   Short Communication 01 June 2017 Pages: 63 - 69

   

9. Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome

   • Erin E. Salo-Mullen
   • Patricio B. Lynn
   • Zsofia K. Stadler

   Short Communication 29 May 2017 Pages: 71 - 77

   

10. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel

    • Naim Abu Freha
    • Yaara Leibovici Weissman
    • Zohar Levi

    Original Article 12 June 2017 Pages: 79 - 86

    

11. Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing

    • Rachel Silva-Smith
    • Daniel A. Sussman

    Short Communication 09 June 2017 Pages: 87 - 90

    

12. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas

    • Mark Clendenning
    • Alvin Huang
    • On behalf of investigators from the Melbourne Collaborative Cohort Study and the Australasian Colorectal Cancer Family Registry Cohort

    Original Article 14 June 2017 Pages: 91 - 100

    

13. Development of a high risk pancreatic screening clinic using 3.0 T MRI

    • Chad A. Barnes
    • Elizabeth Krzywda
    • Susan Tsai

    Original Article 03 November 2017 Pages: 101 - 111

    

14. Gestational choriocarcinoma associated with a germline TP53 mutation

    • Anne-Claire Brehin
    • Sophie Patrier-Sallebert
    • Thierry Frebourg

    Short Communication 05 May 2017 Pages: 113 - 117

    

15. TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma

    • Raissa C. Andrade
    • Maria A. F. D. de Lima
    • Fernando R. Vargas

    Short Communication 05 May 2017 Pages: 119 - 122

    

16. Next generation sequencing is informing phenotype: a TP53 example

    • R. O’Shea
    • R. Clarke
    • D. J. Gallagher

    Original Article 16 May 2017 Pages: 123 - 128

17. Association of genetic variations in RTN4 3′-UTR with risk for clear cell renal cell carcinoma

    • Yan Pu
    • Peng Chen
    • Lin Zhang

    Original Article 07 July 2017 Pages: 129 - 134

18. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion

    • Meike Schneider
    • Katja Dinkelborg
    • Othon Iliopoulos

    Short Communication 16 June 2017 Pages: 135 - 139

    

19. Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families

    • Mev Dominguez-Valentin
    • Sigve Nakken
    • Eivind Hovig

    Original Article 12 June 2017 Pages: 141 - 153

    

20. How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study

    • Sandi Dheensa
    • Gillian Crawford
    • Anneke Lucassen

    Original Article Open access 12 April 2017 Pages: 155 - 166

    

21. The role of screening MRI in the era of next generation sequencing and moderate-risk genetic mutations

    • Sarah Macklin
    • Jennifer Gass
    • Stephanie Hines

    Review 22 June 2017 Pages: 167 - 173

22. A single visit multidisciplinary model for managing patients with mutations in moderate and high-risk genes in a community practice setting

    • Michael P. O’Leary
    • Bryan S. Goldner
    • Hong Yoon Plurad

    Original Article 09 June 2017 Pages: 175 - 178